These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9446410

  • 21. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE, Karafoka E, Papailiou JG, Stamopoulos P, Zambirinis CP, Bramis K, Panoussopoulos SG, Leandros E, Bramis J.
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [Abstract] [Full Text] [Related]

  • 22. p53 protein immunostaining in routinely processed paraffin-embedded sections.
    Bruner JM, Connelly JH, Saya H.
    Mod Pathol; 1993 Mar; 6(2):189-94. PubMed ID: 8483890
    [Abstract] [Full Text] [Related]

  • 23. [The results of p53 immunostaining in colorectal adenomas, early cancers, advanced cancers and their hepatic metastasis].
    Saigusa N, Maruyama K, Sugimura H, Endoh Y, Baba S.
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():159-63. PubMed ID: 8678561
    [Abstract] [Full Text] [Related]

  • 24. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
    Hornick JL, Farraye FA, Odze RD.
    Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
    [Abstract] [Full Text] [Related]

  • 25. Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma.
    Nehls O, Klump B, Holzmann K, Lammering G, Borchard F, Gruenagel HH, Gaco V, Gregor M, Porschen R.
    Cancer; 1999 Jun 15; 85(12):2541-8. PubMed ID: 10375100
    [Abstract] [Full Text] [Related]

  • 26. [Epidemiological study, pathologic evaluation and prognostic factors of colorectal mucinous vs non-mucinous adenocarcinoma (a series of 196 patients)].
    Arfaoui Toumi A, Kriaa Ben Mahmoud L, Khiari M, Lahmer A, Gharbi L, Dhraïef M, Khalfallah T, Regaya Mzabi S, Bouraoui S.
    Tunis Med; 2010 Jan 15; 88(1):12-7. PubMed ID: 20415207
    [Abstract] [Full Text] [Related]

  • 27. p53 as an indicator of lymph node metastases in invasive early colorectal cancer.
    Makino M, Yamane N, Taniguchi T, Honboh T, Kurayoshi K, Kaibara N.
    Anticancer Res; 2000 Jan 15; 20(3B):2055-9. PubMed ID: 10928151
    [Abstract] [Full Text] [Related]

  • 28. Angiogenesis and p53 at the invading tumor edge: prognostic markers for colorectal cancer beyond stage.
    Georgiou L, Minopoulos G, Lirantzopoulos N, Fiska-Demetriou A, Maltezos E, Sivridis E.
    J Surg Res; 2006 Mar 15; 131(1):118-23. PubMed ID: 16325858
    [Abstract] [Full Text] [Related]

  • 29. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM, Reis MM, Palomino SA, Farhat C, Takagaki TY, Beyruti R, Saldiva PH, Capelozzi VL.
    Mod Pathol; 2000 May 15; 13(5):511-20. PubMed ID: 10824922
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
    Ropponen KM, Kellokoski JK, Lipponen PK, Pietiläinen T, Eskelinen MJ, Alhava EM, Kosma VM.
    Br J Cancer; 1999 Sep 15; 81(1):133-40. PubMed ID: 10487624
    [Abstract] [Full Text] [Related]

  • 33. P53 and heat shock protein 70 expressions in colorectal adenocarcinoma.
    Shotar AM.
    Saudi Med J; 2005 Oct 15; 26(10):1602-6. PubMed ID: 16228064
    [Abstract] [Full Text] [Related]

  • 34. Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T1 and T2 Stages and decreased survival time in TNM stages I and II.
    Xu F, Xu J, Lou Z, Di M, Wang F, Hu H, Lai M.
    Am J Surg Pathol; 2009 Sep 15; 33(9):1287-92. PubMed ID: 19471152
    [Abstract] [Full Text] [Related]

  • 35. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
    Edler D, Kressner U, Ragnhammar P, Johnston PG, Magnusson I, Glimelius B, Påhlman L, Lindmark G, Blomgren H.
    Clin Cancer Res; 2000 Feb 15; 6(2):488-92. PubMed ID: 10690528
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
    Li JW, Chuang TC, Yang AH, Hsu CK, Kao MC.
    Int J Oncol; 2005 Apr 15; 26(4):933-43. PubMed ID: 15753987
    [Abstract] [Full Text] [Related]

  • 38. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
    Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M, Noguchi T, Nakayama H, Yasui W.
    J Pathol; 2005 Oct 15; 207(2):185-98. PubMed ID: 16086444
    [Abstract] [Full Text] [Related]

  • 39. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
    Ikeda S, Shimizu Y, Fujimori M, Ishizaki Y, Kurihara T, Ojima Y, Okajima M, Asahara T.
    Clin Cancer Res; 2003 Nov 15; 9(15):5660-5. PubMed ID: 14654549
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.